ANALISIS BIAYA DAN EFEKTIVITAS TERAPI PASIEN DIABETES MELITUS TIPE 2 RAWAT JALAN DI RSUD SLEMAN YOGYAKARTA
Diabetes is a chronical disease that can significantly increase someone�s risk of having complications. These complications are not only cause the inability of the body that will affect the quality of life, but also need the big cost. This research was conducted to analyze the costs and effectiven...
| Main Authors: | , |
|---|---|
| Format: | Thesis |
| Published: |
[Yogyakarta] : Universitas Gadjah Mada
2012
|
| Subjects: |
| _version_ | 1797032432687382528 |
|---|---|
| author | , pratiwi dinaryanti , Prof. Dr. Achmad Fudholi, DEA., Apt |
| author_facet | , pratiwi dinaryanti , Prof. Dr. Achmad Fudholi, DEA., Apt |
| author_sort | , pratiwi dinaryanti |
| collection | UGM |
| description | Diabetes is a chronical disease that can significantly increase someone�s
risk of having complications. These complications are not only cause the inability
of the body that will affect the quality of life, but also need the big cost. This
research was conducted to analyze the costs and effectiveness of therapies of
outpatient with type 2 diabetes mellitus.
A crosssectional observational method was performed on patient who
were admitted to the Department of Endocrinology of the Sleman Hospital
between December 2010zzxvvh to January 2011. The data were taken in 2 ways:
concurrent and retrospective, with accidental sampling technique. The Subject of
this research are out patient with type 2 diabetes mellitus at RSUD Sleman
Yogyakarta, who have used the antidiabetic therapy for at least three months of
therapy before the quality of life measurement. The Costs that are measured are
direct medical costs, antidiabetic costs, complication costs, laboratory
examination costs, and administration costs. The effectiveness of treatment
parameters is measured based on the percentage of patients with fasting blood
glucose level (GDP) and post-prandial blood glucose (GDPP) which reached the
target in the third month of therapy, and achievement of the quality of life
research subjects.
The Lowest total cost of therapy is on the use of glibenclamide, it was Rp.
49.730,00, the highest total cost of therapy is on the use of insulin, it was Rp
411.045,50. T test results with 95% confidence level indicates that the patient
characteristics and medication adherence complications affect the quality of life of
patients, whereas non-pharmacological therapy (exercise and diet) did not
significantly influence the quality of life of patients. The results of measurements
of quality of life showed metformin achieved the best quality of life than the other
antidiabetic, it was 72.53. Based on the effectiveness of the three parameters
(measurement of quality of life and levels of GDP and GDPP) is noted that
metformin therapy tend to be more effective compared with other antidiabetic
therapies. |
| first_indexed | 2024-03-13T22:38:20Z |
| format | Thesis |
| id | oai:generic.eprints.org:99169 |
| institution | Universiti Gadjah Mada |
| last_indexed | 2024-03-13T22:38:20Z |
| publishDate | 2012 |
| publisher | [Yogyakarta] : Universitas Gadjah Mada |
| record_format | dspace |
| spelling | oai:generic.eprints.org:991692016-03-04T08:49:45Z https://repository.ugm.ac.id/99169/ ANALISIS BIAYA DAN EFEKTIVITAS TERAPI PASIEN DIABETES MELITUS TIPE 2 RAWAT JALAN DI RSUD SLEMAN YOGYAKARTA , pratiwi dinaryanti , Prof. Dr. Achmad Fudholi, DEA., Apt ETD Diabetes is a chronical disease that can significantly increase someone�s risk of having complications. These complications are not only cause the inability of the body that will affect the quality of life, but also need the big cost. This research was conducted to analyze the costs and effectiveness of therapies of outpatient with type 2 diabetes mellitus. A crosssectional observational method was performed on patient who were admitted to the Department of Endocrinology of the Sleman Hospital between December 2010zzxvvh to January 2011. The data were taken in 2 ways: concurrent and retrospective, with accidental sampling technique. The Subject of this research are out patient with type 2 diabetes mellitus at RSUD Sleman Yogyakarta, who have used the antidiabetic therapy for at least three months of therapy before the quality of life measurement. The Costs that are measured are direct medical costs, antidiabetic costs, complication costs, laboratory examination costs, and administration costs. The effectiveness of treatment parameters is measured based on the percentage of patients with fasting blood glucose level (GDP) and post-prandial blood glucose (GDPP) which reached the target in the third month of therapy, and achievement of the quality of life research subjects. The Lowest total cost of therapy is on the use of glibenclamide, it was Rp. 49.730,00, the highest total cost of therapy is on the use of insulin, it was Rp 411.045,50. T test results with 95% confidence level indicates that the patient characteristics and medication adherence complications affect the quality of life of patients, whereas non-pharmacological therapy (exercise and diet) did not significantly influence the quality of life of patients. The results of measurements of quality of life showed metformin achieved the best quality of life than the other antidiabetic, it was 72.53. Based on the effectiveness of the three parameters (measurement of quality of life and levels of GDP and GDPP) is noted that metformin therapy tend to be more effective compared with other antidiabetic therapies. [Yogyakarta] : Universitas Gadjah Mada 2012 Thesis NonPeerReviewed , pratiwi dinaryanti and , Prof. Dr. Achmad Fudholi, DEA., Apt (2012) ANALISIS BIAYA DAN EFEKTIVITAS TERAPI PASIEN DIABETES MELITUS TIPE 2 RAWAT JALAN DI RSUD SLEMAN YOGYAKARTA. UNSPECIFIED thesis, UNSPECIFIED. http://etd.ugm.ac.id/index.php?mod=penelitian_detail&sub=PenelitianDetail&act=view&typ=html&buku_id=55176 |
| spellingShingle | ETD , pratiwi dinaryanti , Prof. Dr. Achmad Fudholi, DEA., Apt ANALISIS BIAYA DAN EFEKTIVITAS TERAPI PASIEN DIABETES MELITUS TIPE 2 RAWAT JALAN DI RSUD SLEMAN YOGYAKARTA |
| title | ANALISIS BIAYA DAN EFEKTIVITAS TERAPI
PASIEN DIABETES MELITUS TIPE 2
RAWAT JALAN DI RSUD SLEMAN YOGYAKARTA |
| title_full | ANALISIS BIAYA DAN EFEKTIVITAS TERAPI
PASIEN DIABETES MELITUS TIPE 2
RAWAT JALAN DI RSUD SLEMAN YOGYAKARTA |
| title_fullStr | ANALISIS BIAYA DAN EFEKTIVITAS TERAPI
PASIEN DIABETES MELITUS TIPE 2
RAWAT JALAN DI RSUD SLEMAN YOGYAKARTA |
| title_full_unstemmed | ANALISIS BIAYA DAN EFEKTIVITAS TERAPI
PASIEN DIABETES MELITUS TIPE 2
RAWAT JALAN DI RSUD SLEMAN YOGYAKARTA |
| title_short | ANALISIS BIAYA DAN EFEKTIVITAS TERAPI
PASIEN DIABETES MELITUS TIPE 2
RAWAT JALAN DI RSUD SLEMAN YOGYAKARTA |
| title_sort | analisis biaya dan efektivitas terapi pasien diabetes melitus tipe 2 rawat jalan di rsud sleman yogyakarta |
| topic | ETD |
| work_keys_str_mv | AT pratiwidinaryanti analisisbiayadanefektivitasterapipasiendiabetesmelitustipe2rawatjalandirsudslemanyogyakarta AT profdrachmadfudholideaapt analisisbiayadanefektivitasterapipasiendiabetesmelitustipe2rawatjalandirsudslemanyogyakarta |